用于鱼类脑垂体内分泌研究的离体灌流培育系统

本实验建立了研究鲤鱼脑垂体碎片促性腺激素（ＧｔＨ）和生长激素（ＧＨ）分泌反应的离体灌流系统。性腺退化鲤鱼的脑垂体碎片可产生稳定和可测的ＧｔＨ和ＧＨ基础分泌;引入２ｍｉｎ脉冲式鲑鱼促性腺激素释放激素类似物（ｓＧｎＲＨＡ）可产生敏感的、恢复迅速和可再现的ＧｔＨ和ＧＨ分泌峰。该系统为鱼类脑垂体激素（ＧｔＨ和ＧＨ）分泌动力学和分泌调节机理的离体研究提供了可靠的手段。     

细胞外Ca^＋＋对脉冲式和持续性鲑GnRH类似物刺激鲤GtH分泌的影响

２ｍｉｎ脉冲式１０ｎｍｏｌ鲑ＧｎＲＨ高效类似物ｓＧｎＲＨ－Ａ（Ａｒｇ＾６Ｔｒｐ＾７Ｌｅｕ＾８Ｐｒｏ＾９ＮＥｔ－ＬＨＲＨ）刺激导致离体灌流培育的鲤脑垂体迅速产生显著的ＧｔＨ分泌峰,ＧｔＨ分泌在刺激后３０ｍｉｎ内恢复到基础水平。４ｈ１０ｎｍｏｌ／Ｌ ｓＧｎＲＨ－Ａ持续性刺激导致灌流培育的鲤脑垂体ＧｔＨ分泌出现脱敏反应,整个过程包括刺激后迅速的ＧｔＨ分泌峰相和随后持续低水平的ＧｔＨ分泌相。无Ｃａ＾＋＋的     

激素和人工诱导鱼类繁殖

鱼类在蓄养条件下,由于环境条件变化使脑垂体不能大量分泌产生促性腺激素（ＧｔＨ）因而通常不能自行产卵,必需进行人工催产,许多鱼类的ＧｔＨ分泌活动受神经内分泌双重调节,即促性腺激素释放激素刺激（ＧｎＲＨ）而多巴胺抑制ＧｔＨ的释放,因此,使用高少性的ＧｎＲＨ类似物和多巴胺拮抗物能十分有效地刺激养殖鱼类释放ＧｔＨ和诱导产卵。海水鱼类产卵习性和淡水鱼类不同,还需研制适合海水养殖鱼类生殖生理特性的催产术。     

不同的下丘脑肽和神经递质对鲤鱼促性腺激素和生物激素分泌活动的影响

以１龄性腺发育中期鲤鱼为材料,采用腹腔注射的方法,研究了不同的下丘脑肽和神经递质对鲤鱼促性腺激素和生长激素分泌的影响。结果表明：促甲状腺激素释放激素,Ｌ－多巴,甲基睾酮,γ－氨基丁酸,促黄体素主激素类似物和三磺甲状腺原氨酸者都能显著刺激ＧｔＨ的分泌,但最大效应时间各不相同。     

硬骨鱼类促性腺激素的种类,结构功能及分泌调节的研究进展

促性腺激素（Ｇｏｎａｄｏｔｒｏｐｉｎ,ＧｔＨ）是硬骨鱼类脑垂体分泌的在其生殖周期调节中起中心作用的激素。有关ＧｔＨ种类,结构功能及分泌调节的研究较多,特别是近十年来,随着分子生物学的发展和新的生化技术的应用,这方面研究进展很快,本文综述这方面的进展。...     

多巴胺能药物对鲤鱼促性腺激素分泌活动的影响

研究多巴胺（ＤＡ）及其激动剂阿扑吗啡（ＡＰＯ）和拮抗剂Ｄｏｍｐｅｒｉｄｏｎｅ（ＤＯＭ）对不同性腺发育时期和不同年龄雌鲤促性腺激素（ＧｔＨ）分泌活动的影响。结果表明：鲤鱼基础ＧｔＨ分泌具有明显的季节性变化,表现为血清ＧｔＨ含量在性腺发育早期较低,性腺成熟期升高,到性腺退化期又降低。ＤＡ和ＡＰＯ对ＧｔＨ分泌的抑制作用及ＤＯＭ对ＧｔＨ分泌的刺激作用在不同性腺发育时期为：性腺发育早期〉性腺成熟期〉性腺退化     

不同的下丘脑肽和神经递质对鲤鱼促性腺激素和生长激素分泌活动的影响

以１龄性腺发育中期鲤鱼为材料,采用腹腔（ｉ．ｐ）注射的方法,研究不同的下丘脑肽和神经递质对鲤鱼促性腺激素（ＧｔＨ）和生长激素（ＧＨ）分泌的影响。结果表明：促甲状腺激素释放激素（ＴＲＨ）、Ｌ－多巴（Ｌ－ＤＯＰＡ）、甲基睾酮（ＭＴ）、γ－氨基丁酸（ＧＡＢＡ）、促黄体素释放激素类似物（ＬＨＲＨ－Ａ）和三碘甲状腺原氨酸（Ｔ３）都能显著刺激ＧｔＨ的分泌,但最大效应时间各不相同。ＴＲＨ和ＬＨＲＨ－Ａ能促进ＧＨ的分泌,Ｌ－ＤＯＰＡ、ＭＴ、ＧＡＢＡ对血清ＧＨ水平没有明显影响;Ｔ３则对ＧＨ分泌有一定的抑制作用。这说明鲤鱼ＧｔＨ和ＧＨ的分泌除了受各自的下丘脑释放因子和释放抑制因子的双重神经内分泌调控外,还受多种其它相同和不同调节因子的影响,也反映了鲤鱼ＧｔＨ和ＧＨ分泌的神经内分泌调控的复杂性。     

鲑鱼促性腺激素释放激素（sGnRH）调节鲤鱼脑垂体生长激素分泌的离体研究

ｓＧｎＲＨ同时刺激离体灌流孵育的鲤鱼脑垂体ＧｔＨ和ＧＨ分泌,ＧｔＨ和ＧＨ对ｓＧｎＲＨ脉冲式刺激的分泌反应的时间进程和剂量依存关系相似。生长抑素显著抑制基础的ｓＧｎＲＨ刺激的ＧＨ分泌,但对ＧｔＨ分泌没有影响。阿扑吗啡以剂量依存方式显著抑制基础的ｓＧｎＲＨ促进的ＧｔＨ分泌,并显著刺激ＧＨ分泌,但对ｓＧｎＲＨ促进的ＧＨ分泌无影响。     

蛙类促性腺激素释放激素的研究

蛙类促性腺激素释放激素的研究李远友林浩然（中山大学生物系广州５１０２７５）关键词促性腺激素释放激素特性作用蛙促性腺激素释放激素（ＧｎＲＨ）是脊椎动物脑垂体促性激素（ＧｔＨ）合成和释放的主要调节者,在生殖功能神经激素调控中起关键作用。近年来,哺乳类和...     

促性腺激素释放激素的种类,作用及调节

促性腺激素释放激素的种类、作用及调节禹龙香李远友（湖南农业大学医院,长沙４１０１２８）（中山大学生物系,广州５１０２７５）促性腺激素释放激素（ＧｎＲＨ）是由脊椎动物的脑（主要是视前—下丘脑）产生的一类十肽激素,它在脑垂体促性腺激素（ＧｔＨ）的合成和分...     

Involvement of voltage-dependent calcium channels (VDCC) in the action of GnRH on GtH release in common carp (Cyprinus carpio L): comparison with K+ action.

The involvement of different types of voltage-dependent calcium channels (VDCC) in the stimulatory action of GnRH (in comparison with K+) on maturational gonadotropin (GtH) release was investigated using superfused carp pituitary cells. The action of these 2 stimulants was not modified either by D600 or nifedipine (drugs blocking L-type of VDCC). Cadmium (Cd2+), which blocks all types of VDCC indifferently, provoked a dose-dependent stimulation of GtH secretion. Cd2+ action was not altered by addition of sGnRH in any of the doses. Similar results were obtained using K+ as a secretagogue, but only the highest dose of Cd2+ (200 mumol/l) was able to completely block K+ action. Low doses (0.1 and 1 mumol/l) of the L-type VDCC activator BAY-K8644 did not change basal GtH secretion and had no effect on sGnRH-stimulated GtH secretion. Surprisingly, doses (10 mumol/l and higher) of BAY-K8644 evoked dose-dependent inhibition of GtH secretion. On the other hand, a higher concentration (20 mumol/l) of nifedipine provoked a stimulation of GtH release. Our results indicate that the stimulatory action of GnRH and K+ involves activation of a certain type of cadmium-sensitive VDCC (probably T- or N-type VDCC) whereas dihydropyridine and diphenylalkylamine sensitive VDCC (L-type VDCC) does not participate in this phenomenon. The inhibitory action of BAY-K8644 and, on the other hand, the stimulatory action of nifedipine indicate that L-type VDCC probably play a role in other physiological pathways regulating GtH release in carp.     

Evaluation of in vitro incubation systems for the study of gonadotropin release.

A detailed study was undertaken in order to determine if a pituitary-half incubation system were a suitable model for the study of anterior pituitary response to estradiol and LHRH. Considerable variation in the gonadotropin content of randomized pituitary halves was observed. Much less variation was found in matched halves. During the initial thirty minutes incubation of pituitary halves, a large spontaneous release of gonadotropins was observed. Time course secretion studies indicated that by four hours incubation, in the presence of 50 ng/ml LHRH, cumulative secretion of LH and FSH had far exceeded that of controls. Elevations in both cumulative secretion and rate of secretion were evident within 15-30 minutes of incubation. Regardless of LHRH dose, only 2-4% of either gonadotropin was secreted. Estradiol in the range of 10, 100, 500, 1,000 and 50,000 pg/ml had no significant effect on pituitary response to LHRH or on basal release, tissue levels or total gonadotropin. Based on these results, it was concluded that while the pituitary-half incubation system may be suitable for studying LHRH induced gonadotropin secretion, it is apparently of insufficient sensitivity to allow the collection of meaningful data concerning the effects of estradiol alone on gonadotropin secretion or estradiol modulation of LHRH induced gonadotropin secretion.     

A regulator of G Protein signaling, RGS3, inhibits gonadotropin-releasing hormone (GnRH)-stimulated luteinizing hormone (LH) secretion

Background  

Luteinizing hormone secreted by the anterior pituitary gland regulates gonadal function. Luteinizing hormone secretion is regulated both by alterations in gonadotrope responsiveness to hypothalamic gonadotropin releasing hormone and by alterations in gonadotropin releasing hormone secretion. The mechanisms that determine gonadotrope responsiveness are unknown but may involve regulators of G protein signaling (RGSs). These proteins act by antagonizing or abbreviating interaction of Gα proteins with effectors such as phospholipase Cβ. Previously, we reported that gonadotropin releasing hormone-stimulated second messenger inositol trisphosphate production was inhibited when RGS3 and gonadotropin releasing hormone receptor cDNAs were co-transfected into the COS cell line. Here, we present evidence for RGS3 inhibition of gonadotropin releasing hormone-induced luteinizing hormone secretion from cultured rat pituitary cells.     

Metformin decreases GnRH- and activin-induced gonadotropin secretion in rat pituitary cells: potential involvement of adenosine 5' monophosphate-activated protein kinase (PRKA)

Metformin is an insulin sensitizer molecule used for the treatment of infertility in women with polycystic ovary syndrome and insulin resistance. It modulates the reproductive axis, affecting the release of gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH). However, metformin's mechanism of action in pituitary gonadotropin-secreting cells remains unclear. Adenosine 5' monophosphate-activated protein kinase (PRKA) is involved in metformin action in various cell types. Here, we investigated the effects of metformin on gonadotropin secretion in response to activin and GnRH in primary rat pituitary cells (PRP), and studied PRKA in rat pituitary. In PRP, metformin (10 mM) reduced LH and follicle-stimulating hormone (FSH) secretion induced by GnRH (10(-8) M, 3 h), FSH secretion, and mRNA FSHbeta subunit expression induced by activin (10(-8) M, 12 or 24 h). The different subunits of PRKA are expressed in pituitary. In particular, PRKAA1 is detected mainly in gonadotrophs and thyrotrophs, is less abundant in lactotrophs and somatotrophs, and is undetectable in corticotrophs. In PRP, metformin increased phosphorylation of both PRKA and acetyl-CoA carboxylase. Metformin decreased activin-induced SMAD2 phosphorylation and GnRH-induced mitogen-activated protein kinase (MAPK) 3/1 (ERK1/2) phosphorylation. The PRKA inhibitor compound C abolished the effects of metformin on gonadotropin release induced by GnRH and on FSH secretion and Fshb mRNA induced by activin. The adenovirus-mediated production of dominant negative PRKA abolished the effects of metformin on the FSHbeta subunit mRNA and SMAD2 phosphorylation induced by activin and on the MAPK3/1 phosphorylation induced by GnRH. Thus, in rat pituitary cells, metformin decreases gonadotropin secretion and MAPK3/1 phosphorylation induced by GnRH and FSH release, FSHbeta subunit expression, and SMAD2 phosphorylation induced by activin through PRKA activation.     

The effect of opioid peptides on ovine pituitary gonadotropin secretion in vitro

Although a hypothalamic site of action has been firmly established for opiate-mediated gonadotropin regulation, there have been several reports which indicate the possibility of a direct influence on the pituitary gland. The objective of this study was to further investigate this possibility in an in vitro pituitary perifusion system utilizing ovine tissue. Treatment with gamma-endorphin (GE) or human beta-endorphin (hBE) resulted in elevated basal LH release (p less than 0.05), followed by an inhibition in the response to a subsequent GnRH challenge (p less than 0.05). The stimulatory effect of hBE was found to be dose-responsive (p less than 0.01). PRL secretion was not similarly stimulated. Ovine beta-endorphin (oBE) had no effect on LH secretion, even though it differs from hBE by only 2 amino acids and contains the active GE sequence. Met-enkephalin also did not influence gonadotropin secretion. Naloxone pretreatment did not reverse the effects of hBE on gonadotropin release. It was found, however, that [D-pGlu1, D-Phe2, D-Trp3,6]-GnRH, a specific GnRH receptor antagonist, did reduce hBE-induced LH and FSH release (p less than 0.05). Naloxone pretreatment alone suppressed the response to GnRH (p less than 0.05). These data indicate that certain opioid peptides can influence ovine gonadotropin secretion in vitro by activating the GnRH receptor. Furthermore, a facilitory role is suggested for endogenous opiates in the local regulation of pituitary gonadotropin secretion.     

Dependence of secretory responses to gonadotropin-releasing hormone on diacylglycerol metabolism. Studies with a diacylglycerol lipase inhibitor, RHC 80267

The role of diacylglycerol (DG) as a source of arachidonic acid during gonadotropin-releasing hormone (GnRH) stimulation of gonadotropin secretion was analyzed in primary cultures of rat anterior pituitary cells. An inhibitor of DG lipase (RHC 80267, RHC) caused dose-dependent blockade of GnRH-stimulated luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion. The DG lipase inhibitor did not alter gonadotropin responses to arachidonic acid, and addition of arachidonic acid reversed its inhibition of GnRH-stimulated LH and FSH release. In [3H]arachidonic acid-prelabeled cells, incubation with RHC increased the accumulation of [3H]DG. These results suggest that DG lipase participates in GnRH action and that arachidonic acid mobilization from DG is involved in the mechanism of gonadotropin release. Gonadotropin responses to tetradecanoyl phorbol acetate and dioctanoyl glycerol were not altered by RHC, and the addition of these activators of protein kinase C (Ca2+- and phospholipid-dependent enzyme) did not prevent the inhibition of GnRH-induced gonadotropin release by RHC. Activation of phospholipase A2 by melittin increased LH and FSH secretion, whereas blockade of this enzyme by quinacrine reduced GnRH-stimulated hormone release. However, RHC did not diminish the gonadotropin response to melittin. The inhibitory actions of RHC and quinacrine were additive and were reversed by concomitant treatment with arachidonic acid. Ionomycin also increased LH and FSH release, and the gonadotropin responses to the ionophore were unaltered by RHC but were reduced by quinacrine. Incubation of cells in Ca2+-depleted (+/- [ethylenebis(oxyethylenenitrilo)]tetraacetic acid) medium reduced but did not abolish the LH and FSH releasing activity of GnRH. Treatment with RHC also reduced the gonadotropin responses to GnRH under Ca2+-depleted conditions. These observations indicate that RHC inhibition of GnRH action is not due to nonspecific actions on Ca2+ entry, protein kinase C activation and actions, nor phospholipase A2 enzyme activity. The results of this study provide further evidence for an extracellular Ca2+-independent mechanism of GnRH action, and suggest that GnRH causes mobilization of arachidonic acid by two distinct lipases, namely, phospholipase A2 and DG lipase, during stimulation of gonadotropin secretion.     

Regulation of gonadotropin secretion and puberty onset by neuromedin U

Neuromedin U (NMU), an anorexigenic peptide, was originally isolated from porcine spinal cord in 1985. As NMU is abundant in the anterior pituitary gland, we investigated the effects of NMU on gonadotropin secretion. Both NMU and its receptors, NMUR1 and NMUR2, were expressed in the pituitary gland. NMU suppressed LH and FSH releases from rat anterior pituitary cells. Moreover, NMU-deficient mice exhibit an early onset of vaginal opening. The LHbeta/FSHbeta ratio, which is an index of puberty onset, is high in young NMU-deficient mice. These results indicate that NMU suppresses gonadotropin secretion and regulates the onset of puberty.     

Desensitization of pituitary gonadotropin secretion by agonist-induced inactivation of voltage-sensitive calcium channels

Gonadotropin-releasing hormone (GnRH) stimulates calcium mobilization and influx in pituitary gonadotrophs, and agonist-induced calcium entry through voltage-sensitive channels (VSCC) is required for the maintenance of gonadotropin secretion. However, prolonged or frequent exposure to GnRH attenuates the extracellular Ca2+-dependent cytosolic Ca2+ signal and diminishes hormone secretion. Measurements of membrane Ca2+ currents revealed significant impairment of VSCC activity in gonadotrophs during desensitization by GnRH. VSSC were also inactivated in a calcium-dependent manner during exposure to high K+. Prolonged inactivation of such Ca2+ channels by high K+ reduced the calcium and secretory responses to GnRH and vice versa. The calcium-dependent inactivation of VSCC during GnRH action appears to be a primary factor in the onset of desensitization in pituitary gonadotrophs. This mechanism could also account for the development of agonist-induced refractoriness in other calcium-regulated target cells.     

Rapid recovery of estrogen-induced pituitary gonadotropin surges after luteectomy in rhesus monkeys

In the presence of a functional corpus luteum, positive estrogen feedback on the surge modes of gonadotropin secretion is blocked in rhesus monkeys. We investigated the effects of luteectomy (Lx) on the time required for recovery of pituitary responsiveness (LH/FSH surges) to positive estrogen feedback. Estradiol-17 beta-3- benzoate (EB, 50 microgram/kg sc) was given: 1) 24th prior to, 2) the day of, or 3) 24 h after luteal ablation. Daily measurements of serum follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol-17 beta (e2) and progesterone (P) were made on each monkey for 5 days. Serum P fell to undetectable levels within 24 h after Lx, whereas E2 levels in circulation peaked within 24h after injection of EB. Among early follicular phase monkeys, this EB treatment results in typical midcycle type LH/FSH surges within 48h. Lx alone was not soon followed by significant changes in pituitary gonadotropin secretion. When circulating P levels were undetectable the pituitary responded fully to EB; that is, typical midcycle type FSH/LH surges occurred. When serum P was in the midst of declining after Lx, gonadotropin surges were present, but attenuated. However, when P levels remained elevated for more than 24 h after EB injection, the surge modes of FSH/LH secretion remained fully blocked. These results demonstrate that the suppressive influence of luteal secretions (principally progesterone) on positive estrogen feedback regulation of the surge modes of pituitary gonadotropin secretion is quite transient in these primates.     

Regulation of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) gene expression by gonadotropin-releasing hormone (GnRH) and sexual steroids in the Mediterranean Sea bass

The secretion of gonadotropins, the key reproductive hormones in vertebrates, is controlled from the brain by the gonadotropin-releasing hormone (GnRH), but also by complex steroid feedback mechanisms. In this study, after the recent cloning of the three gonadotropin subunits of sea bass (Dicentrarchus labrax), we aimed at investigating the effects of GnRH and sexual steroids on pituitary gonadotropin mRNA levels, in this valuable aquaculture fish species. Implantation of sea bass, in the period of sexual resting, for 12 days with estradiol (E2), testosterone (T) or the non-aromatizable androgen dihydrotestosterone (DHT), almost suppressed basal expression of FSHbeta (four to 15-fold inhibition from control levels), while slightly increasing that of alpha (1.5-fold) and LHbeta (approx. twofold) subunits. Further injection with a GnRH analogue (15 microg/kg BW; [D-Ala6, Pro9-Net]-mGnRH), had no effect on FSHbeta mRNA levels, but stimulated (twofold) pituitary alpha and LHbeta mRNA levels in sham- and T-implanted fish, and slightly in E2- and DHT-implanted fish (approx. 1.5-fold). The GnRHa injection, as expected, elevated plasma LH levels with a parallel decrease on LH pituitary content, with no differences between implanted fish. In conclusion, high circulating steroid levels seems to exert different action on gonadotropin secretion, inhibiting FSH while stimulating LH synthesis. In these experimental conditions, the GnRHa stimulate LH synthesis and release, but have no effect on FSH synthesis.